CRISPR-edited allogeneic anti-CLL-1 CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CRISPR-edited allogeneic anti-CLL-1 CAR-T cell therapy, covering 2025-06-11 to 2025-06-11. Get the full timeline:
Most recent: Clinical Trial Update: CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]